this is
a demo
text file
test test

Amid a raging controversy over
The efficacy of covaxin,India's first indigenous covid-19 vaccine
reputed medical journal the Lancet Infectious Diseases on friday said the vaccine produced tolerate saftey outcomes and enhansed immune responses in its phase 1 trial.
